Please assess the completion status of the following clinical trial:

Trial Title: Benefit of Dual-chamber Pacing With Closed Loop Stimulation (CLS) in Tilt-induced Cardioinhibitory Reflex Syncope

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Patients affected by clinical diagnosis of reflex syncope who meet all the following criteria:~* age \>=40 years~* significant limitation of social and working life due to unpredictable or frequent syncope recurrences, ≥2 within the last year.~* type 2B cardio-inhibitory response to TT (according to the VASIS classification).~* Alternative therapies have failed or were not feasible.~* exclusion of other possible competitive causes of syncope.~Exclusion Criteria:~- Any other indication to IPG, implantable defibrillator (ICD), cardiac resynchronization therapy (CRT), according to current guidelines~Any cardiac dysfunctions possibly leading to loss of consciousness:~* overt heart failure;~* ejection fraction (LVEF) \<40% (Echo-assessed within 3-month prior to study participation);~* myocardial infarction;~* diagnosis of hypertrophic or dilated cardiomyopathy;~* clinically significant valvular disease;~* sinus bradycardia \<50 bpm or sinoatrial block;~* Mobitz I second-degree atrioventricular block;~* Mobitz II second or third-degree atrioventricular block;~* bundle-branch block;~* rapid paroxysmal supraventricular tachycardia or ventricular tachycardia;~* preexcited QRS complexes;~* prolonged QT interval;~* Brugada syndrome;~* arrhythmogenic right ventricular cardiomyopathy~* Symptomatic orthostatic hypotension diagnosed by standing BP measurement;~* Nonsyncopal loss of consciousness (eg, epilepsy, psychiatric, metabolic, drop-attack, cerebral transient ischemic attack, intoxication, cataplexy).~* Symptomatic cardioinhibitory carotid sinus hypersensitivity.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- DDD+CLS (Type: EXPERIMENTAL): The pacemaker will be programmed in a dual-chamber DDD pacing mode with the Closed Loop Stimulation (CLS) function ON.
- ODO (Type: PLACEBO_COMPARATOR): The pacemaker will be programmed in ODO mode.

Based on this trial design, predict the completion outcome and termination type (if applicable).